有两个股票很让我迷惑 - 未名空间MITBBS历史存档

国际科技财经博客移民网络热点娱乐民生时事公众号

Redian新闻

>未名空间

>Stock

有两个股票很让我迷惑

有两个股票很让我迷惑# Stock

j*72010-10-14 07:10

1 楼

HGSI － Advisory Committees 马上就要决定了，不但没来高潮，还退潮了。我知道
它的药的疗效有点shaky，用药时间长了反而不灵光了，不过就凭它一年的数据搞个
通过应该不难吧。不过这公司其它的compound都TMD是垃圾。
VRTX －药效没的说，好就一个字，股价呢，萎就一个字。难道就是因为不想卖身
，就遭到大家的抛弃吗？

p*y2010-10-14 07:10

2 楼

大牛给pick了，赞！

【在 j*****7 的大作中提到】

: HGSI － Advisory Committees 马上就要决定了，不但没来高潮，还退潮了。我知道
: 它的药的疗效有点shaky，用药时间长了反而不灵光了，不过就凭它一年的数据搞个
: 通过应该不难吧。不过这公司其它的compound都TMD是垃圾。
: VRTX －药效没的说，好就一个字，股价呢，萎就一个字。难道就是因为不想卖身
: ，就遭到大家的抛弃吗？

l*n2010-10-14 07:10

3 楼

go for vrtx
NEW YORK (Market Intellisearch) -- Unusual volume of call contracts was
traded today. There were 2,771 call contracts traded compared to the ten day
average volume of 498 contracts. On the put side, 1,057 put contracts
exchanged hands. Today's traded Put/Call ratio is 0.38. There were 2.62
calls traded for each put contract.

【在 j*****7 的大作中提到】

j*72010-10-14 07:10

4 楼

１）不是大牛，你见过这波没参与的大牛吗？
２）不是给pick，我也不明白，希望明白人进来讨论一下

【在 p*****y 的大作中提到】

: 大牛给pick了，赞！

c*02010-10-14 07:10

5 楼

银杏帮忙看看biod

【在 j*****7 的大作中提到】

j*72010-10-14 07:10

6 楼

今天小捞了一把HGSI。目标33 - 35 after advisory committee meeting.

C*i2010-10-14 07:10

7 楼

怎么看下周22号的ARNA？扑的量蛮大的

j*72010-10-14 07:10

8 楼

没戏。

【在 C*******i 的大作中提到】

: 怎么看下周22号的ARNA？扑的量蛮大的

C*i2010-10-14 07:10

9 楼

谢。

【在 j*****7 的大作中提到】

: 没戏。

J*e2010-10-14 07:10

10 楼

After advisory meeting?
It will be either double or go to below $10 depending on the result.

【在 j*****7 的大作中提到】

: 今天小捞了一把HGSI。目标33 - 35 after advisory committee meeting.

J*e2010-10-14 07:10

11 楼

HGSI他们增发了吗？
我感觉是不是有内部消息，他们在FDA之前要增发啊？

【在 j*****7 的大作中提到】

j*72010-10-14 07:10

12 楼

Nobody believes FDA will decline the approval, it hit the endpoint w/o any
question.
The real deal is the expected sales number, since this drug didn't work very
well at 78 wk, so there might not be huge sales after its approval, that's
the reason I said I'd close my position once price spikes. On the other hand
, if FDA delayed the approval, it'd be a nice entry point.

【在 J********e 的大作中提到】

: After advisory meeting?
: It will be either double or go to below $10 depending on the result.

J*e2010-10-14 07:10

13 楼

You are highly possible right.
But it is going to be the first and only drug for lupus, even if the effect
at 78-
week is gone, patients still need to use it. What I heard is the market
potential is
4B. So I assume if it is approved, there still should be a strike of the
stock price.
If the FDA declines it, it is really up to the letter. If there is some
safety
concern or more clinical trials required, then the price can go ugly.
Have they offered stocks recently?
That is always the major concern of pre-FDA run.

very
s
hand

【在 j*****7 的大作中提到】

: Nobody believes FDA will decline the approval, it hit the endpoint w/o any
: question.
: The real deal is the expected sales number, since this drug didn't work very
: well at 78 wk, so there might not be huge sales after its approval, that's
: the reason I said I'd close my position once price spikes. On the other hand
: , if FDA delayed the approval, it'd be a nice entry point.

j*72010-10-14 07:10

14 楼

If FDA declines the approval, wow, it'd be around $5. I don't think it has
many of serious AEs, at least I have never heard any safety cercons, in fact
, almost all analysts believe it will get approved.
If approved, my guess it'd spike to around 35 then who knows. But I am
always a conservative trader, I have no problem selling it around 33.

effect

【在 J********e 的大作中提到】

: You are highly possible right.
: But it is going to be the first and only drug for lupus, even if the effect
: at 78-
: week is gone, patients still need to use it. What I heard is the market
: potential is
: 4B. So I assume if it is approved, there still should be a strike of the
: stock price.
: If the FDA declines it, it is really up to the letter. If there is some
: safety
: concern or more clinical trials required, then the price can go ugly.

h*82010-10-14 07:10

15 楼

今早咋回事？
震盘？没敢捞。

fact

【在 j*****7 的大作中提到】

: If FDA declines the approval, wow, it'd be around $5. I don't think it has
: many of serious AEs, at least I have never heard any safety cercons, in fact
: , almost all analysts believe it will get approved.
: If approved, my guess it'd spike to around 35 then who knows. But I am
: always a conservative trader, I have no problem selling it around 33.
:
: effect

S*r2010-10-14 07:10

16 楼

I was a little worried in this morning after I bought the last batch of
planned position this morning). How low can this go? I still believe the
drug will pass the panel review on Nov 19 and get approved at end of this
year. I doubled my original position to 1400 shares to 2800 shares.